| Product NDC: | 57844-215 |
| Proprietary Name: | GALZIN |
| Non Proprietary Name: | Zinc Acetate |
| Active Ingredient(s): | 25 mg/1 & nbsp; Zinc Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 57844-215 |
| Labeler Name: | Gate Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020458 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970128 |
| Package NDC: | 57844-215-52 |
| Package Description: | 250 CAPSULE in 1 BOTTLE (57844-215-52) |
| NDC Code | 57844-215-52 |
| Proprietary Name | GALZIN |
| Package Description | 250 CAPSULE in 1 BOTTLE (57844-215-52) |
| Product NDC | 57844-215 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zinc Acetate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19970128 |
| Marketing Category Name | NDA |
| Labeler Name | Gate Pharmaceuticals |
| Substance Name | ZINC ACETATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE] |